As Dry Eye Awareness Month kicks off, Bausch + Lomb is rolling out a new campaign to improve education about the condition.

Bausch + Lomb and Walmart team up to offer free eye care clinics, samples, and education during Healthy Vision Month at 40 stores.

The recall of intraocular lenses is currently being wrapped up by Bausch + Lomb, after reports of inflammatory reactions following cataract surgery.

Bausch + Lomb (NYSE:BLCO) stock drops as the company lowers its growth outlook after lower than expected Q1 2025 financials. Read more here.

By Adriano Marchese Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the eye care unit’s ratings will continue to be under pressure unless the ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...

Recall issued in response to reports of toxic anterior segment syndrome. HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the ...

The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety concerns. The company said it was recalling several of its enVista ...

Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company received reports of complications, the cause of which could not immediately be ...

Bausch + Lomb (NYSE:BLCO – Get Free Report)‘s stock had its “equal weight” rating reissued by research analysts at Wells Fargo & Company in a research note issued to investors on Friday ...